ESTIA HEALTH LIMITED (EHE)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

EHE - ESTIA HEALTH LIMITED

FNArena Sector : Aged Care & Seniors
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 1.36
Index: ASX300 | ALL-ORDS

Estia Health is an Australian provider of aged care homes and respite care. It operates over 65 facilities across Australia. Founded in 2005, it was floated on the ASX in 2014.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$2.57

02 Jun
2023

0.040

OPEN

$2.52

1.58%

HIGH

$2.57

274,467

LOW

$2.49

TARGET
$2.75 7.0% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
EGH . INA . LIC . OCA . REG .
FNARENA'S MARKET CONSENSUS FORECASTS
EHE: 1
Title FY21
Actual
FY22
Actual
FY23
Forecast
FY24
Forecast
EPS (cps) xxx - 20.1 11.5 xxx
DPS (cps) xxx 2.4 11.9 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx 2.2% 100.0% xxx
PE Ratio xxx N/A 22.3 xxx
Dividend Yield xxx N/A 4.6% xxx
Div Pay Ratio(%) xxx N/A 103.5% xxx

Dividend yield today if purchased 3 years ago: 1.43%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.91

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 24/02 - ex-div 3.7c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 201720182019202020212022
EPS Basic xxxxxxxxxxxxxxx-20.1
DPS All xxxxxxxxxxxxxxx2.4
Sales/Revenue xxxxxxxxxxxxxxx671.1 M
Book Value Per Share xxxxxxxxxxxxxxx210.1
Net Operating Cash Flow xxxxxxxxxxxxxxx55.5 M
Net Profit Margin xxxxxxxxxxxxxxx-7.80 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201720182019202020212022
Return on Capital Employed xxxxxxxxxxxxxxx-9.05 %
Return on Invested Capital xxxxxxxxxxxxxxx-7.03 %
Return on Assets xxxxxxxxxxxxxxx-2.79 %
Return on Equity xxxxxxxxxxxxxxx-9.05 %
Return on Total Capital xxxxxxxxxxxxxxx1.76 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx11.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201720182019202020212022
Short-Term Debt xxxxxxxxxxxxxxx4 M
Long Term Debt xxxxxxxxxxxxxxx157 M
Total Debt xxxxxxxxxxxxxxx161 M
Goodwill - Gross xxxxxxxxxxxxxxx817 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx20 M
Price To Book Value xxxxxxxxxxxxxxx0.91

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201720182019202020212022
Capex xxxxxxxxxxxxxxx33.5 M
Capex % of Sales xxxxxxxxxxxxxxx4.99 %
Cost of Goods Sold xxxxxxxxxxxxxxx622 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx36 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx1 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

22/02/2023

1

Outperform

$2.75

7.00%

First half results revealed a benefit from improving occupancy and greater government funding. Underlying EBITDA was 15% ahead of Macquarie's forecasts.

Combined with recent acquisitions, the broker envisages several factors will support strong earnings growth in FY24 and FY25. Outperform retained. Target rises to $2.75 from $2.50.

FORECAST
Macquarie forecasts a full year FY23 dividend of 11.90 cents and EPS of 11.50 cents.
Macquarie forecasts a full year FY24 dividend of 15.60 cents and EPS of 14.40 cents.

EHE STOCK CHART